E. McDermott

503 total citations
15 papers, 438 citations indexed

About

E. McDermott is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, E. McDermott has authored 15 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Genetics. Recurrent topics in E. McDermott's work include Estrogen and related hormone effects (5 papers), Cell death mechanisms and regulation (2 papers) and HER2/EGFR in Cancer Research (2 papers). E. McDermott is often cited by papers focused on Estrogen and related hormone effects (5 papers), Cell death mechanisms and regulation (2 papers) and HER2/EGFR in Cancer Research (2 papers). E. McDermott collaborates with scholars based in Ireland, United States and United Kingdom. E. McDermott's co-authors include N. J. O’Higgins, Leonie S. Young, Thomas B. Crotty, Fergal J. Fleming, Denis Mehigan, Gabrielle Kelly, E. Myers, Michael K. O’Malley, A Hill and Arnold Hill and has published in prestigious journals such as Biochemical and Biophysical Research Communications, British Journal of Cancer and Annals of Oncology.

In The Last Decade

E. McDermott

14 papers receiving 428 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E. McDermott Ireland	10	233	147	136	70	44	15	438
Victoria Fabris Argentina	13	262 1.1×	270 1.8×	206 1.5×	126 1.8×	56 1.3×	25	540
Toshihide Nishishita Japan	12	325 1.4×	101 0.7×	48 0.4×	50 0.7×	42 1.0×	13	476
Hirofumi Akashi Japan	11	329 1.4×	140 1.0×	69 0.5×	169 2.4×	48 1.1×	17	573
N. Brünner Denmark	9	205 0.9×	181 1.2×	172 1.3×	150 2.1×	24 0.5×	12	456
Kristopher Krueger United States	8	259 1.1×	113 0.8×	85 0.6×	122 1.7×	33 0.8×	12	423
G. Sica Italy	13	166 0.7×	123 0.8×	105 0.8×	80 1.1×	75 1.7×	43	415
Jean‐Marc Rey France	8	191 0.8×	127 0.9×	184 1.4×	99 1.4×	31 0.7×	12	401
Séverine Cunat France	10	171 0.7×	138 0.9×	198 1.5×	98 1.4×	33 0.8×	24	527
Y. Buggy United Kingdom	9	248 1.1×	190 1.3×	102 0.8×	99 1.4×	20 0.5×	13	439
Shauntae M. McDaniel United States	7	212 0.9×	306 2.1×	65 0.5×	120 1.7×	64 1.5×	7	519

Countries citing papers authored by E. McDermott

Since Specialization

Citations

This map shows the geographic impact of E. McDermott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. McDermott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. McDermott more than expected).

Fields of papers citing papers by E. McDermott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. McDermott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. McDermott. The network helps show where E. McDermott may publish in the future.

Co-authorship network of co-authors of E. McDermott

This figure shows the co-authorship network connecting the top 25 collaborators of E. McDermott. A scholar is included among the top collaborators of E. McDermott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. McDermott. E. McDermott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Phillips, K L, Nicholas F. Wright, E. McDermott, & Neil A. Cross. (2019). TRAIL responses are enhanced by nuclear export inhibition in osteosarcoma. Biochemical and Biophysical Research Communications. 517(2). 383–389. 3 indexed citations

Gremel, Gabriela, Máirín Rafferty, Fiona Lanigan, et al.. (2011). Functional and prognostic relevance of the homeobox protein MSX2 in malignant melanoma. British Journal of Cancer. 105(4). 565–574. 12 indexed citations

Pierce, John P., Radka Saldova, Umi Marshida Abd Hamid, et al.. (2010). Levels of specific glycans significantly distinguish lymph node-positive from lymph node-negative breast cancer patients. Glycobiology. 20(10). 1283–1288. 39 indexed citations

Tormey, Shona, Carmel Malone, E. McDermott, N. J. O’Higgins, & Arnold D. Hill. (2006). Current Status of Combined Hormone Replacement Therapy in Clinical Practice. Clinical Breast Cancer. 6. S51–S57. 9 indexed citations

Prichard, R S, Arnold Hill, E. McDermott, N. J. O’Higgins, & Leonie S. Young. (2005). Growth factor activation of the mitogen-activated protien (MAP) kinase pathway increases breast coactivator protein expression and stimulates breast tumourigenesis. Irish Journal of Medical Science (1971 -). 174(S1). 24–24. 1 indexed citations

Hill, A, et al.. (2004). Novel actions of the anti-estrogen faslodex at the estrogen receptor. 7.

Fleming, Fergal J., E. Myers, Gabrielle Kelly, et al.. (2004). Expression of SRC-1, AIB1, and PEA3 in HER2 mediated endocrine resistant breast cancer; a predictive role for SRC-1. Journal of Clinical Pathology. 57(10). 1069–1074. 107 indexed citations

Teh, Swee H., et al.. (2004). COX inhibitors modulate bFGF‐induced cell survival in MCF‐7 breast cancer cells. Journal of Cellular Biochemistry. 91(4). 796–807. 24 indexed citations

Ryan, Bríd M., Norma O’Donovan, Brigid C. Browne, et al.. (2004). Expression of survivin and its splice variants survivin-2B and survivin-ΔEx3 in breast cancer. British Journal of Cancer. 92(1). 120–124. 87 indexed citations

10.

Daly, Peter A., Andrew Green, W. Ormiston, et al.. (2003). Predictive testing for BRCA1 and 2 mutations: a male contribution. Annals of Oncology. 14(4). 549–553. 32 indexed citations

11.

Lim, Kheng Tian, Swee H. Teh, Arnold Hill, et al.. (2002). Direct pro-angiogenic and indirect pro-metastatic properties of VEGF/VEGF receptors. Irish Journal of Medical Science (1971 -). 171(S2). 66–66. 1 indexed citations

12.

Zbar, Andrew P., et al.. (1997). A 25 year review of parotid surgery.. PubMed. 90(6). 228–30. 8 indexed citations

13.

Gough, Martin, et al.. (1992). Perforation of Bladder Carcinoma Presenting as Acute Abdomen. British Journal of Urology. 69(5). 541–542. 15 indexed citations

14.

Duffy, M. J., J.P. Brouillet, David Reilly, et al.. (1991). Cathepsin D concentration in breast cancer cytosols: correlation with biochemical, histological, and clinical findings. Clinical Chemistry. 37(1). 101–104. 49 indexed citations

15.

O’Malley, Michael K., E. McDermott, Denis Mehigan, & N. J. O’Higgins. (1989). Role for prazosin in reducing the development of rabbit intimal hyperplasia after endothelial denudation. British journal of surgery. 76(9). 936–938. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact